SCHEMBL24143293

SCHEMBL24143293

CC(C)CCn1cc(CCNSN(C)C)c2ccc(-c3ccncc3)cc21

nearest known ligand 0.57

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ NR1D1 P20393 20/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24144679 0.85 NR1D1 (0.49) NR1D1
SCHEMBL24144264 0.85 NR1D1 (0.52) NR1D1
SCHEMBL24143302 0.84 NR1D1 (0.48) NR1D1
SCHEMBL24143299 0.83 NR1D1 (0.82) NR1D1
SCHEMBL24144280 0.83 NR1D1 (0.40) NR1D1
SCHEMBL24143250 0.82 NR1D1 (0.49) NR1D1
SCHEMBL24144895 0.82 NR1D1 (0.59) NR1D1
SCHEMBL24144642 0.82 NR1D1 (0.49) NR1D1
SCHEMBL24144342 0.81 NR1D1 (0.48) NR1D1
SCHEMBL24143542 0.81 NR1D1 (0.53) NR1D1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021263278-A1 REV-ERB AGONISTS FOR THE TREATMENT OF TH17-MEDIATED INFLAMMATORY DISORDERS THE SCRIPPS RESEARCH INSTITUTE (US) 2021-12-30 — — WO disclosed
Send feedback